Form D · Other

ARB Labs Inc.

Toronto, A6 · CIK 0001893038

Offering snapshot reported Nov 10, 2021 · SEC filing

Reported sold
$50K
Offering amount: $50K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 9, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 10, 2021Initial$50,000No comparison1SEC filing
Nov 10, 2021Initial$387,041No comparison1SEC filing
Nov 10, 2021Initial$79,524No comparison1SEC filing
Nov 10, 2021Initial$75,464No comparison1SEC filing
Nov 10, 2021Initial$300,000No comparison1SEC filing
Nov 10, 2021Initial$82,875No comparison1SEC filing
Nov 10, 2021Initial$400,025No comparison1SEC filing
Nov 10, 2021Initial$116,464No comparison1SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-420622
U.S. dollar amounts calculated based on USD$1.00=CAD$1.299983.
common shares @ CAD$115.00 per share.

Source: Form D, filed Nov 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Debbie Bush Executive
Andrzej Kepinski Director, Executive
Connor O'hearn Executive
Connor O?Hearn Executive
Marvin Singer Director
Brett Story Director

Issuer details

Industry: Other (See others in industry)

Address:
1240 Bay Street, Suite 504
Toronto, A6, M5R 3N7